Home ›

New HIV prevention technologies and their implications for HIV prevention in Canada - a Webinar Series

CATIE, the Interagency Coalition on AIDS and Development (ICAD), the Canadian AIDS Society (CAS), and the Canadian Public Health Association (CPHA) present a webinar series exploring new HIV prevention technologies (NPTs) and their implications for HIV prevention in the Canadian context.

The following five webinars were offered in July and August in both English and French:

Webinar 1: New HIV prevention technologies (NPTs)- The basics and the state of the research

If you're wondering what all the buzz is around new HIV prevention technologies, you're not alone. Recent research advances have reinvigorated the field, with new findings around medical male circumcision, vaccines, microbicides and ARV-based prevention strategies.

Join this webinar to learn about the basics of new HIV prevention technologies – what they are, what the research tells us and what it means in the Canadian context.

Click here to watch a recording of the webinar and/or download the powerpoint slides

Webinar 2: Preparing for NPTs – Learning from the past and preparing for the future

New prevention technologies like PrEP, microbicides and vaccines are starting to show promise in research studies. Advances in research raise questions about the challenges that exist for roll out in communities, how to ensure equitable access and how to successfully incorporate NPTs into the wider HIV prevention landscape.

Join this webinar to learn about what's already known about the potential challenges to NPT roll out and how to prepare for an HIV prevention landscape that includes NPTs.

Click here to watch a recording of the webinar and/or download the powerpoint slides

Webinar 3: Can we prevent infection with HIV after an exposure? The world of post-exposure prophylaxis (PEP)

Much of the work we do in HIV prevention is aimed at trying to stop people from engaging in behaviours that could expose them to HIV and potentially lead to infection. But what happens if someone thinks they may have recently been exposed to HIV? Is there a way we can stop them from getting infected? Post-exposure prophylaxis, or PEP, could be an option.

Join this webinar to learn about how PEP works, when it can be used, and why it isn't more available for certain types of exposures.

Watch a recording of the webinar (Internet Explorer only), view the slides, download a PDF, and/or listen to the audio recording (.asf).

Webinar 4: Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection

What if a person at risk of HIV infection could start taking preventative medications on a regular basis before being exposed to HIV in order to reduce their risk of infection? This strategy, known as pre-exposure prophylaxis (or PrEP), is beginning to show promise in research studies and could potentially provide another much needed prevention option for those at risk of infection. Despite its promise, this strategy raises a number of concerns and – if we aren't prepared – its introduction could end up doing more harm than good.

Join this webinar to learn about the PrEP research, the concerns that PrEP raises, and how we can make sure these concerns are avoided.

Watch a recording of the webinar (Internet Explorer only), view the slides, download a PDF, and/or listen to the audio recording (.asf).

Webinar 5: Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention

You may have heard that people living with HIV are less likely to pass HIV to others if they are on treatment - a strategy often referred to as "treatment as prevention"- but many misconceptions and unanswered questions still remain. How effective is treatment at reducing the risk of transmission? Does an undetectable blood viral load mean that someone can't transmit HIV through unprotected sex? What exactly is a "test and treat" strategy?

Join this webinar to learn the answers to these questions and get updated on the latest research.

Watch a recording of the webinar (Internet Explorer only), view the slides, download a PDF, and/or listen to the audio recording (.asf).